chartexchange

Climb Bio and Mabworks Announce CLYM116/MIL116 Data Demonstrating Deep, Durable APRIL Suppression and ~70% Gd-IgA1 Reduction at ASN Kidney Week 2026

GlobeNewswire Inc. | Oct 23, 2026 4:01 PM EDT

>90% free APRIL suppression sustained through 12 weeks, supporting Q12W dosing interval

Read original article